Press Releases

ARLINGTON, Mass., Aug. 21, 2019 /PRNewswire/ -- Third Pole Therapeutics, a privately held company developing and delivering transformative life-saving cardio-pulmonary therapies, announced today that the U.S. Patent and Trademark Office has recently issued U.S. patents covering Third Pole's innovative general and portable inhaled Nitric Oxide (iNO) deliv

BOONTON, N.J., Aug. 21, 2019 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary oral peptide delivery technologies, 

WASHINGTON, Aug. 21, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients, today announced that it has named Aranthan "AJ" Jones II as its Chief Corporate Affairs and Communic

NEW YORK, Aug. 21, 2019 /PRNewswire/ -- Arsenal Capital Partners ("Arsenal"), a leading specialized private equity firm investing in specialty industrials and healthcare companies, announced today the addition of Michael Bernstein to its healthcare team.  Mr. Bernstein will join as an Operating Partner and will focus on investments in

CONCORD, Mass., Aug. 21, 2019 /PRNewswire/ -- JF Healthcare, a medical diagnostic start-up based in Nanchang, China, is the first organization in the world to

VANCOUVER, British Columbia, and PHOENIX, Aug. 21, 2019 /PRNewswire/ -- 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company") will report, after market close on August 29, 2019, the unaudited interim financial results of 4Front Holdings LLC for the second quar

CARLSBAD, Calif., Aug. 21, 2019 /PRNewswire/ -- Progenitor Biologics®, LLC, the manufacturer and distributor of the revolutionary, evidence-based, anti-aging skincare products,

TORONTO and PARK CITY, Utah, Aug. 21, 2019 /PRNewswire/ -- DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, announced today three promotions. Gabe Becher was promoted to Managing Director; Eric Moore to Principal; and

NEW YORK, Aug. 21, 2019 /PRNewswire/ -- The GO2 Foundation for Lung Cancer, the United States' leading lu

HONG KONG, Aug. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter fiscal 2020 on Tuesday, August 27, 2019, after the market close.  The Company will host a conference call at 8:00 a.m. ET on